Wellgistics Health, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WGRX research report →
Price Chart
About the company
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise.
- CEO
- Prashant Patel
- IPO
- 2025
- Employees
- 31
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on WGRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.67M
- P/E
- -0.07
- PEG
- 0.00
- P/S
- 1.00
- P/B
- -0.41
- EV/EBITDA
- -0.68
- Div Yield
- 0.00%
- Gross Margin
- -125.11%
- Op Margin
- -719.27%
- Net Margin
- -1100.30%
- ROE
- 877.58%
- ROIC
- -439.90%
Latest fiscal year · YoY change
- Revenue
- $23.34M+28.7%
- Gross Profit
- $-9,637,483-645.3%
- Op Income
- $-81,194,831
- Net Income
- $-101,274,530-1377.1%
- EPS
- $-71.50-1000.0%
- OCF Growth
- -786.1%
- FCF Growth
- -577.5%
- 52W High
- $97.50
- 52W Low
- $2.48
- 50D MA
- $3.76
- 200D MA
- $14.75
- Beta
- -1.46
- RSI (14)
- 55
- Avg Volume
- 563.90K
No earnings-call transcripts are available for WGRX yet.
- Free Float
- 17.7%
- Shares Outstanding
- 2.46M
- Float Shares
- 436.91K
of shares held by institutions
19 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 851.12K | ▲ 111.88K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 21, 25 | Kalla Srinivas | other | 0 |
| Apr 22, 25 | DiSiena Mark | other | 0 |
| Mar 21, 25 | Pirani Shafaat | other | 35,000 |
| Mar 21, 25 | Syed Sajid | other | 200,000 |
| Mar 21, 25 | AJJARAPU SURENDRA K | other | 600,000 |
| Mar 21, 25 | AJJARAPU SURENDRA K | other | 600,000 |
| Mar 21, 25 | AJJARAPU SURENDRA K | other | 2,882,247 |
| Mar 21, 25 | Patel Prashant | other | 1,882,247 |
| Mar 21, 25 | Patel Prashant | other | 1,500,000 |
| Mar 21, 25 | Patel Prashant | other | 700,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our WGRX coverage
Recent articles, reports, and earnings notes.
No research on WGRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WGRX report →DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
accessnewswire.com · Jul 22
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
prnewswire.com · Jul 21
Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
accessnewswire.com · Jul 20
Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.
globenewswire.com · Jul 16
Wellgistics Health Appoints Brett Thompson as Chief Technology Officer
accessnewswire.com · Jul 15
Wellgistics Health Executive Chairman and President Exercise Warrants
accessnewswire.com · Jun 30
DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc.
accessnewswire.com · Jun 26
Wellgistics Health Provides Mid-Year 2026 Corporate Outlook
accessnewswire.com · Jun 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.